Literature DB >> 9585295

Quantifying oral analgesic consumption using a novel method and comparison with patient-controlled intravenous analgesic consumption.

H W Striebel1, W Scheitza, W Philippi, U Behrens, S Toussaint.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9585295     DOI： 10.1097/00000539-199805000-00027

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  5 in total

1.  Patient-controlled oral analgesia for postoperative pain management following total knee replacement.

Authors:  Patti Kastanias; Sue Gowans; Paul S Tumber; Kianda Snaith; Sandra Robinson
Journal:  Pain Res Manag       Date:  2010 Jan-Feb       Impact factor: 3.037

Review 2.  Patient-Controlled Analgesia (PCA): Intravenous Administration (IV-PCA) versus Oral Administration (Oral-PCA) by Using a Novel Device (PCoA® Acute) for Hospitalized Patients with Acute Postoperative Pain-A Comparative Retrospective Study.

Authors:  Stefan Wirz; Stefanie Seidensticker; Ronit Shtrichman
Journal:  Pain Res Manag       Date:  2021-05-04       Impact factor: 3.037

3.  Patient directed self management of pain (PaDSMaP) compared to treatment as usual following total knee replacement: study protocol for a randomized controlled trial.

Authors:  Simon Donell; Katherine Deane; Louise Swift; Garry Barton; Paula Balls; Clare Darrah; Richard Gray
Journal:  Trials       Date:  2012-11-05       Impact factor: 2.279

4.  Factors associated with success and failure of patient-controlled oral analgesia after total hip and knee arthroplasty: a historical comparative cohort study.

Authors:  Leon Vorobeichik; Yasmine Hoydonckx; Pranab Kumar; Arlene Buzon-Tan; Susan Walker; Kyle Kirkham; Dharini Ilangomaran; Lashmi Venkatraghavan; Atul J Prabhu; Anuj Bhatia
Journal:  Can J Anaesth       Date:  2020-11-17       Impact factor: 6.713

5.  Patient-directed self-management of pain (PaDSMaP) compared to treatment as usual following total knee replacement; a randomised controlled trial.

Authors:  Katherine H O Deane; Richard Gray; Paula Balls; Clare Darrah; Louise Swift; Alan B Clark; Garry R Barton; Sophie Morris; Sue Butters; Angela Bullough; Helen Flaherty; Barbara Talbot; Mark Sanders; Simon T Donell
Journal:  BMC Health Serv Res       Date:  2018-05-10       Impact factor: 2.655
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.